Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Richard Rauck, D. Alexander Oh, Neha Parikh, Christian Koch, Neil Singla, Jin Yu, Srinivas Nalamachu & Santosh Vetticaden. (2017) Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a single ascending dose study in opioid-naïve healthy volunteers. Current Medical Research and Opinion 33:11, pages 1915-1920.
Read now
Read now
Andrew Chang, Eric J. Roeland, Rabia S. Atayee, Carolyn Revta & Joseph D. Ma. (2015) Transmucosal Immediate-Release Fentanyl for Breakthrough Cancer Pain: Opportunities and Challenges for Use in Palliative Care. Journal of Pain & Palliative Care Pharmacotherapy 29:3, pages 247-260.
Read now
Read now
Sebastiano Mercadante & Antonino Giarratano. (2014) Assessing age and gender in studies of breakthrough pain medications. Current Medical Research and Opinion 30:7, pages 1353-1356.
Read now
Read now
Susan M. Moeschler, Casandra Rosenberg, Drew Trainor, Richard H. Rho & W. David Mauck. (2014) Interventional Modalities to Treat Cancer-Related Pain. Hospital Practice 42:5, pages 14-23.
Read now
Read now
Howard S Smith. (2013) Considerations in selecting rapid-onset opioids for the management of breakthrough pain. Journal of Pain Research 6, pages 189-200.
Read now
Read now
Donald R Taylor. (2013) Single-dose fentanyl sublingual spray for breakthrough cancer pain. Clinical Pharmacology: Advances and Applications 5, pages 131-141.
Read now
Read now
Nicholas Moore, Mona Darwish, Xavier Amores & Hélène Schneid. (2012) A review of the pharmacokinetic profile of transmucosal fentanyl formulations. Current Medical Research and Opinion 28:11, pages 1781-1790.
Read now
Read now
Articles from other publishers (31)
Judith A. Paice, Kari Bohlke, Debra Barton, David S. Craig, Areej El-Jawahri, Dawn L. Hershman, Lynn R. Kong, Geana P. Kurita, Thomas W. LeBlanc, Sebastiano Mercadante, Kristina L. M. Novick, Ramy Sedhom, Carole Seigel, Joanna Stimmel & Eduardo Bruera. (2023) Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline. Journal of Clinical Oncology 41:4, pages 914-930.
Crossref
Crossref
Hironori MawatariTakuya ShinjoTatsuya MoritaHiroyuki KoharaKinomi Yomiya. (2022) Revision of Pharmacological Treatment Recommendations for Cancer Pain: Clinical Guidelines from the Japanese Society of Palliative Medicine. Journal of Palliative Medicine 25:7, pages 1095-1114.
Crossref
Crossref
Senthil Marappan, Vigneshwaran Subramanian, Brindha Rathinasabapathy, Elvis Senthil & Shiladitya Bose. (2022) Comparative study between 2-chloroprocaine and combination of 2-chloroprocaine with fentanyl for spinal anaesthesia. Serbian Journal of Anesthesia and Intensive Therapy 44:5-6, pages 139-145.
Crossref
Crossref
Ethan Williamson, Kelley L. Sharp & Steven D. Waldman. 2021. Pain Control in Ambulatory Surgery Centers. Pain Control in Ambulatory Surgery Centers
133
152
.
Mari Fihlman, E. Karru, P. Varpe, H. Huhtinen, N. Hagelberg, T. I. Saari & K. T. Olkkola. (2020) Feasibility of a transmucosal sublingual fentanyl tablet as a procedural pain treatment in colonoscopy patients: a prospective placebo-controlled randomized study. Scientific Reports 10:1.
Crossref
Crossref
Sebastiano Mercadante, Vincenzo Restivo & Alessandra Casuccio. (2019) Effects of age and gender in patients receiving doses of opioids for breakthrough pain proportional to background opioid doses. Supportive Care in Cancer 28:8, pages 3813-3818.
Crossref
Crossref
Francesca Ricchini, Augusto Caraceni, Ernesto Zecca, Alessandra Pigni, Fabio Centurioni, Andrea Manzoni, Stein Kaasa & Cinzia Brunelli. (2019) Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial. Journal of Pain and Symptom Management 58:4, pages 587-595.
Crossref
Crossref
Jennifer S. Gewandter, Michael P. McDermott, Hua He, Shan Gao, Xueya Cai, John T. Farrar, Nathaniel P. Katz, John D. Markman, Stephen Senn, Dennis C. Turk & Robert H. Dworkin. (2019) Demonstrating Heterogeneity of Treatment Effects Among Patients: An Overlooked but Important Step Toward Precision Medicine. Clinical Pharmacology & Therapeutics 106:1, pages 204-210.
Crossref
Crossref
M. Fallon, R. Giusti, F. Aielli, P. Hoskin, R. Rolke, M. Sharma & C.I. Ripamonti. (2018) Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Annals of Oncology 29, pages iv166-iv191.
Crossref
Crossref
Q. Liu, L.-L. Gao, Y.-L. Dai, Y.-X. Li, Y. Wang, C.-F. Bai, G.-X. Mu, X.-M. Chai, W.-J. Han, L.-J. Zhou, Y.-J. Zhang, L. Tang, J. Liu & J.-Q. Yu. (2018) Nitrous oxide/oxygen mixture for analgesia in adult cancer patients with breakthrough pain: A randomized, double-blind controlled trial. European Journal of Pain 22:3, pages 492-500.
Crossref
Crossref
Jeannine Brant, Barbara Rodgers, Eva Gallagher & Thiruppavai Sundaramurthi. (2017) Breakthrough Cancer Pain: A Systematic Review of Pharmacologic Management
. Clinical Journal of Oncology Nursing 21:3, pages 71-80.
Crossref
Crossref
Stephan A. Schug & Sonya Ting. (2017) Fentanyl Formulations in the Management of Pain: An Update. Drugs 77:7, pages 747-763.
Crossref
Crossref
Richard RauckJanet BullNeha ParikhLarry DillahaLisa Stearns. (2016) Effective Dose Titration of Fentanyl Sublingual Spray in Patients With Breakthrough Cancer Pain. Pain Practice 16:8, pages 1012-1018.
Crossref
Crossref
David S Alberts, Christina Cognata Smith, Neha Parikh & Richard L Rauck. (2016) Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl. Pain Management 6:5, pages 427-434.
Crossref
Crossref
Harold Minkowitz, Janet Bull, R. Charles Brownlow, Neha Parikh & Richard Rauck. (2016) Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain. Supportive Care in Cancer 24:6, pages 2669-2675.
Crossref
Crossref
Thomas W. LeBlanc, Lynn J. Howie & Amy P. Abernethy. 2016. Supportive Cancer Care. Supportive Cancer Care
127
137
.
Giovambattista Zeppetella & Andrew N Davies. (2015) Opioids for the management of breakthrough pain in cancer patients. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Richard RauckNeha ParikhLarry DillahaJerry BarkerLisa Stearns. (2015) Patient Satisfaction with Fentanyl Sublingual Spray in Opioid-Tolerant Patients with Breakthrough Cancer Pain. Pain Practice 15:6, pages 554-563.
Crossref
Crossref
Morten Thronæs, Lars Popper, Martin Eeg, Ellen Jaatun, Magnar Kvitberg & Stein Kaasa. (2015) Efficacy and Tolerability of Intranasal Fentanyl Spray in Cancer Patients With Breakthrough Pain. Clinical Therapeutics 37:3, pages 585-596.
Crossref
Crossref
Theodore H. Stanley. (2014) The Fentanyl Story. The Journal of Pain 15:12, pages 1215-1226.
Crossref
Crossref
Furio Zucco, Cesare Bonezzi & Diego Fornasari. (2014) Breakthrough Cancer Pain (BTcP): a Synthesis of Taxonomy, Pathogenesis, Therapy, and Good Clinical Practice in Adult Patients in Italy. Advances in Therapy 31:7, pages 657-682.
Crossref
Crossref
Sebastiano MercadanteGiampiero PorzioVittorio Gebbia. (2014) New Opioids. Journal of Clinical Oncology 32:16, pages 1671-1676.
Crossref
Crossref
Andrew N. Davies. (2014) Breakthrough Cancer Pain. Current Pain and Headache Reports 18:6.
Crossref
Crossref
Roberta Granata, Paolo Bossi, Rossella Bertulli & Luigi Saita. (2014) Rapid-Onset Opioids for the Treatment of Breakthrough Cancer Pain: Two Cases of Drug Abuse: Table 1. Pain Medicine 15:5, pages 758-761.
Crossref
Crossref
Giovambattista Zeppetella & Andrew N Davies. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Gillian Bedard, Philippa Hawley, Liying Zhang, Marissa Slaven, Pierre Gagnon, Stuart Bisland, Margaret Bennett, Francois Tardif & Edward Chow. (2013) A survey of Canadian cancer patients’ perspectives on the characteristics and treatment of breakthrough pain. Supportive Care in Cancer 21:9, pages 2557-2563.
Crossref
Crossref
Neha Parikh, Venkat Goskonda, Ashok Chavan & Larry Dillaha. (2013) Pharmacokinetics and Dose Proportionality of Fentanyl Sublingual Spray: a Single-Dose 5-Way Crossover Study. Clinical Drug Investigation 33:6, pages 391-400.
Crossref
Crossref
Giovambattista Zeppetella. (2013) Fentanyl Sublingual Spray for Breakthrough Pain in Cancer Patients. Pain and Therapy 2:1, pages 1-9.
Crossref
Crossref
Neha Parikh, Venkat Goskonda, Ashok Chavan & Larry Dillaha. (2013) Single-Dose Pharmacokinetics of Fentanyl Sublingual Spray and Oral Transmucosal Fentanyl Citrate in Healthy Volunteers: A Randomized Crossover Study. Clinical Therapeutics 35:3, pages 236-243.
Crossref
Crossref
Jörn Lötsch, Carmen Walter, Michael J. Parnham, Bruno G. Oertel & Gerd Geisslinger. (2012) Pharmacokinetics of Non-Intravenous Formulations of Fentanyl. Clinical Pharmacokinetics 52:1, pages 23-36.
Crossref
Crossref
Donald R TaylorDonald Taylor. 2013. Managing Cancer Breakthrough Pain. Managing Cancer Breakthrough Pain
29
66
.